参考文献/References:
[1] SIEGEL R L, MILLER K D, JEMAL A. Cancer Statistics. [ J] . CA: a cancer journal for clinicians, 2017, 67( 1) : 7 -30.
[2] OTTOMAN R E, LANGDON E A, ROCHLIN D B, et al.slde - efffects of combined radiatlon and chemotherapy inthe treatment of malignant tumors [ J] . Radiology, 1963,81( 6) : 1014 -1017.
[3] PALESTY J A, WANG W, JAVLE M M, et al. Sideeffects of therapy: case 3. Gastric cancer after radiotherapy of pediatric Hodgkin's disease [ J] . Journal of ClinicalOncology Official Journal of the American Society of Clinical Oncology, 2004, 22( 12) : 2507.
[4] BOULIKAS T, VOUGIOUKA M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs ( review) [ J] . Oncology Reports, 2004, 11( 3) : 559 -561.
[5]高丽娜.中医内科学[M].太原:山西科技出版社,2015.
[6]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
[7]周岱翰.中医肿瘤学[M].北京:中国中医药出版社,2011.
[8]任健.中医诊断学[M].北京:中国医药科技出版社,2015.
[9] Ruidong Lee. Dynamic changes of cellular immune function and individualized adjustments of immunosup - pressant for the management of severe infection after livertransplantation [ J] . Chin J Transplant. 2011, 32 ( 7) :411 -414.
[10] TOUGERON D, MABY P, ELIE N, et al. Regulatory TLymphocytes Are Associated with Less Aggressive Histologic Features in Microsatellite - Unstable Colorectal Cancers [ J] . Plos One, 2013, 8( 4) : e61001.
[11] RAMíREZ M F, HUITINK J M, CATA J P. Perioperative Clinical Interventions That Modify the Immune Response in Cancer Patients [ J] . Open Journal of Anesthesiology, 2013, 3( 3) : 133 -139.
[12] KIMURA A, KISHIMOTO T. IL -6: Regulator of Treg/Th17 balance [ J] . European Journal of Immunology,2010, 40( 7) : 1830 -1735.
[13] BRAGA W M T, SILVA B R D, CARVALHO A C D, etal. FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4 + Tregulatory cells [ J] . Cancer Immunology Immunotherapy,2014, 63( 11) : 1189 -1197.
[14] DILLON P M, OLSON W C, CZARKOWSKI A, et al. Amelanoma helper peptide vaccine increases Th1 cytokineproduction by leukocytes in peripheral blood and immunized lymph nodes [ J] . Journal for ImmunoTherapy ofCancer,2,1( 2014 -07 -15) , 2014, 2( 1) : 23.
[15] NETEA M G, JW V D M, SUTMULLER R P, et al.From the Th1/ Th2 Paradigm towards a Toll - Like Receptor/ T - Helper Bias [ J] . Antimicrobial Agents & Chemotherapy, 2005, 49( 10) : 3991 -3996.
[16] CHUNG A S, WU X, ZHUANG G, et al. An interleukin-17 - mediated paracrine network promotes tumor resistance to anti - angiogenic therapy [ J] . Nature Medicine,2013, 19( 9) : 1114 -1123.
[17] WILSON N, BONIFACE K, CHAN J, et al. Development, cytokine profile and function of human interleukin17 - producing helper T cells [ J] . Nat Immunol, 2007, 8( 9) : 950 -957.
[18] WHITESIDE T L. Regulatory T cell subsets in humancancer: are they regulating for or against tumor progression[ J] . Cancer Immunology Immunotherapy, 2014, 63( 1) :67 -72.
[19] MITEVA L, STANILOV N, CIROVSKI G, et al. Upregulation of Treg - Related Genes in Addition with IL6Showed the Significant Role for the Distant Metastasis in Colorectal Cancer [ J] . Cancer Microenviron, 2017, 10( 1-3) : 69 -76.
[20] NICCOLAI E, RICCI F, RUSSO E, et al. The DifferentFunctional Distribution of " Not Effector" T Cells ( Treg/Tnull) in Colorectal Cancer [ J] . Frontiers in Immunology, 2017, ( 8) :1900.
[ 21] JOHDI N, AIT - TAHAR K, SAGAP I, et al. MolecularSignatures of Human Regulatory T Cells in ColorectalCancer and Polyps [ J] . Frontiers in Immunology, 2017,13( 8) :620.
[22]杨瑶瑶.非小细胞肺癌患者中医证候与免疫等指标的相关性研究[D].北京:中国中医研究院,2010.
[23]马萌.肿瘤微环境及其中医证本质—中医现代化路径之探索[J].中华中医药杂志,2018,33(6):2255-2261.
[24] CHEN T, LI Q, ZHANG X, et al. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T - cell density and Fusobacterium nu
cleatum infection [ J] . Hum Pathol, 2018,
[25] WHITESIDE T L. What are regulatory T cells ( Treg)regulating in cancer and why? [ J] . Seminars in CancerBiology, 2012, 22( 4) : 327 -334.
[26] OLGUíN J, MEDINA - ANDRADE I, MOLINA E, etal. Early and Partial Reduction in CD4Foxp3 Regulatory TCells during Colitis - Associated Colon Cancer InducesCD4 and CD8 T Cell Activation Inhibiting Tumorigenesis[ J] .J Cancer, 2018, 9(2): 239 -249.
[27]刘永刚.康力欣胶囊联合辨证中药维持治疗晚期结直肠癌的临床观察[J].中医临床研究,2018,10(11):53-54.
[28]曾惠锋.化疗联合中药治疗在结直肠癌术后的临床效果分析[J].中医临床研究,2018,10(2):52-53.
[29]李会江,王会生,郝晓尊.化疗联合中药治疗在结直肠癌术后的临床效果[J].世界最新医学信息文摘,2017,17(A1):88-89.
[30] WANG K, GONG H, CHAI R, et al. Aberrant frequency of IL - 35 producing B cells in colorectal cancer patients [ J] . Cytokine, 2018, 10( 2) :206 -210.
[31]朱伟嵘,高蓓莉,焦丽静,等.扶正治癌组方联合表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌临床疗效观察[J].中华中医药杂志,2018,33(8):3692-3697.
相似文献/References:
[1]陈冬 俞森权 朱红叶 姚成 陈滨海 郑健 曹莹 高文仓 庞德湘.阿片类药物诱导便秘的中医证型研究[J].陕西中医药大学学报,2019,(05):089.[doi:10.13424/j.cnki.jsctcm.2019.05.021]
[2]谭为华 王辉 肖光志 丁蓓 曾珍 刘丽英 胡贵香 周中成.2型糖尿病中医证型分布与四时气候相关性的调查研究[J].陕西中医药大学学报,2018,(05):123.[doi:DOI:10.13424/j.cnki.jsctcm.2018.05.036]
Tan Weihua,Wang Hui,Xiao Guangzhi,et al.Investigation on the Relationship between the Distribution of TCM Syndrome Types and the Four Seasons in Type 2 Diabetes[J].Journal of Shaanxi University of Traditional Chinese Medicine,2018,(03):123.[doi:DOI:10.13424/j.cnki.jsctcm.2018.05.036]
[3]李玲,呼兴华,王凌,等.老年人 T2DM合并下肢动脉粥样硬化疾病不同证型间相关指标分析[J].陕西中医药大学学报,2020,(01):084.[doi:10.13424/j.cnki.jsctcm.2020.01.021]
[4]丁涛?汪瀚.无创诊断对肝豆状核变性肝硬化评估及中医证型分析的作用[J].陕西中医药大学学报,2021,44(05):074.[doi:10.13424/j.cnki.jsctcm.2021.05.015]
DING TaoWANG Han.Effects of Noninvasive Diagnosis on Evaluation of Hepatolenticular Degeneration and Cirrhosis and Analysis of TCM Syndrome Types[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(03):074.[doi:10.13424/j.cnki.jsctcm.2021.05.015]
[5]俞婧 田蓓文 梁岩.复发性口腔溃疡影响因素及证型临床调查研究[J].陕西中医药大学学报,2022,(06):054.[doi:10.13424/j.cnki.jsctcm.2022.06.010]
YU Jing TIAN Beiwen LIANG Yan.Clinical Investigation on Influencing Factors and Syndrome
Types of Recurrent Oral Ulcer[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(03):054.[doi:10.13424/j.cnki.jsctcm.2022.06.010]